(Q36150688)

12 August 2017

1 reference

title

A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy (English)

1 reference

chronic inflammatory demyelinating polyradiculoneuropathy

12 August 2017

main subject

0 references

author name string

Jean-Marc Léger

series ordinal

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

Expert Opinion on Pharmacotherapy

12 August 2017

published in

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

569-582

1 reference

Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Treatment of immune neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Chronic inflammatory demyelinative polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Multifocal motor neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Distal acquired demyelinating symmetric neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Mycophenolate in treatment-resistant inflammatory neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Mycophenolate Mofetil for Myasthenia Gravis A Double‐Blind, Placebo‐Controlled Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

The AMC Linear Disability Score project in a population requiring residential care: psychometric properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Neuropathy and monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Successful treatment of IgM paraproteinaemic neuropathy with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Treatment of IgM antibody associated polyneuropathies using rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Efficacy of intravenous immunoglobulin in patients with IgG monoclonal gammopathy and polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

Multifocal motor neuropathy: response to human immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.4.569

21 January 2018

Identifiers

DOI

10.1517/14656566.6.4.569

1 reference

12 August 2017

1 reference